Sanofi reduces US insulin prices for the uninsured

While bills to introduce a price cap on insulin are being discussed in the US Senate, Sanofi has beaten them to the punch and reduced the price of insulin products for US diabetes patients without insurance.
Photo: BENOIT TESSIER/REUTERS / X07241
Photo: BENOIT TESSIER/REUTERS / X07241
by christopher due karlsson, translated by catherine brett

On Friday, French pharmaceutical firm Sanofi reduced its insulin price for uninsured patients in the US significantly. This comes as the Affordable Insulin Now Act has passed the House of Representatives, and a bi-partisan bill to cap costs is being introduced to the Senate.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading